Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:06 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 590 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Diagnostic Ultrasound System Clear all

Conditions: Uterine Fibroid
Interventions: Body System - Functional; Device
Lead sponsor: InSightec; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2026
U.S. locations: 3
States / cities: Los Angeles, California • Stanford, California • Rochester, Minnesota

Conditions: Prostate Carcinoma
Interventions: Shear Wave Elastography, Ultrasound Elasticity Imaging, Ultrasound-Guided Prostate Biopsy; Procedure
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Laxity; Skin
Interventions: Ultherapy Prime; Device
Lead sponsor: The Levine Center for Plastic Surgery; Other
Eligibility: 25 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Amputation, Prosthesis User
Interventions: Sonomyographic Prosthesis, Myoelectric direct control prosthesis, Myoelectric pattern recognition prosthesis; Device
Lead sponsor: George Mason University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Fairfax, Virginia

Conditions: Endometriosis, Endometrioma
Interventions: Radiotracer Injection, Imaging, Rectal Ultrasound Gel Injection; Drug · Diagnostic Test · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 60 participants
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Breast Cancer Stage
Interventions: Imagio; Device
Lead sponsor: Seno Medical Instruments Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Laparoscopic Cholecystectomy, Liver Ablation
Interventions: LapAR; Device
Lead sponsor: Raj Shekhar; Other
Eligibility: 1 Year to 80 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Ankle Fractures
Interventions: Long-Acting Local Anesthesia, Regional Anesthesia; Drug
Lead sponsor: Lahey Clinic; Other
Eligibility: 18 Years to 89 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Burlington, Massachusetts

Conditions: Carcinoma, Hepatocellular, Cirrhosis
Interventions: Abbreviated Magnetic Resonance Imaging with serum AFP, Abdominal Ultrasound Screening with serum AFP; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 75 Years
Enrollment: 4,700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2031
U.S. locations: 34
States / cities: Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 31 more

Conditions: Localized Intermediate Risk Prostate Lesions
Interventions: ExAblate MR Guided Focused Ultrasound; Device
Lead sponsor: InSightec; Industry
Eligibility: 50 Years and older · Male only
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2021
U.S. locations: 9
States / cities: Duarte, California • Los Angeles, California • Stanford, California + 5 more

Conditions: Benign Prostatic Hyperplasia, Localized Prostate Cancer
Interventions: Robotic Waterjet Treatment; Device
Lead sponsor: PROCEPT BioRobotics; Industry
Eligibility: Up to 80 Years · Male only
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: La Mesa, California • Glenview, Illinois • Alexandria, Virginia

Conditions: Anesthesia, Local
Interventions: Not listed
Lead sponsor: Avanos Medical; Other
Eligibility: 18 Years and older
Enrollment: 767 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 8
States / cities: Washington D.C., District of Columbia • Gulf Breeze, Florida • Miami, Florida + 5 more

Conditions: Distal Radius Fracture, Rehabilitation
Interventions: DELFI PTS ii portable tourniquet; Device
Lead sponsor: Brooke Army Medical Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Undifferentiated Pleomorphic Sarcoma
Interventions: ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound (MRgFUS); Device
Lead sponsor: Matthew Bucknor; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Malignant Solid Neoplasm
Interventions: Biospecimen Collection, Computed Tomography, Endobronchial Ultrasound Bronchoscopy, Interstitial Photodynamic Therapy, Palliative Radiation Therapy, Physical Performance Testing, Questionnaire Administration, Verteporfin, Laser: ML7710-PDT; Procedure · Radiation · Other + 2 more
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 2
States / cities: Buffalo, New York • Philadelphia, Pennsylvania

Conditions: Prostate Carcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8
Interventions: MRI-Guided Transurethral Ultrasound Ablation, Questionnaire Administration, Digital Rectal Examination, Cystoscopy, Biopsy, Bone Scan, PSMA PET Scan, Multiparametric Magnetic Resonance Imaging; Procedure · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 45 Years to 80 Years · Male only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Renal Cancer, Tumor, Solid, Kidney Cancer, Tumor, Tumor, Benign
Interventions: HistoSonics Edison System; Device
Lead sponsor: HistoSonics, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 15
States / cities: Los Angeles, California • Mission Viejo, California • New Haven, Connecticut + 10 more

Conditions: Facial Acne
Interventions: Ulthera System Treatment; Device
Lead sponsor: Ulthera, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 2
States / cities: Woodland Hills, California • Charlotte, North Carolina

Conditions: Prostate Disease, Elevated Prostate Specific Antigen, Family History of Prostate Cancer, Positive Digital Rectal Exam, Prostate Cancer
Interventions: Prostate Biopsy, MR US Fusion Guided Prostate Biopsy, MR/TRUS Fusion Guided Prostate Biopsy; Other · Device
Lead sponsor: Ardeshir Rastinehad; Other
Eligibility: 18 Years and older · Male only
Enrollment: 1,586 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 3
States / cities: Lake Success, New York • New York, New York

Conditions: Skin Laxity
Interventions: Ulthera® System Treatment, Heavy Water; Device · Other
Lead sponsor: Ulthera, Inc; Industry
Eligibility: 30 Years to 65 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Pasadena, California

Conditions: Alzheimer Disease
Interventions: Blood Brain Barrier (BBB) Disruption; Device
Lead sponsor: InSightec; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2030
U.S. locations: 10
States / cities: Delray Beach, Florida • Fort Lauderdale, Florida • Gainesville, Florida + 7 more

Conditions: Parkinson's Disease
Interventions: ExAblate Transcranial System; Device
Lead sponsor: InSightec; Industry
Eligibility: 30 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 5
States / cities: Stanford, California • Baltimore, Maryland • Boston, Massachusetts + 2 more

Conditions: Mild to Moderate Skin Laxity Under the Chin, Mild to Moderate Skin Laxity on Neck
Interventions: Microfocused ultrasound with visualization; Device
Lead sponsor: Merz North America, Inc.; Industry
Eligibility: 35 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 7
States / cities: Los Gatos, California • San Diego, California • Vista, California + 4 more

Conditions: Parkinson's Disease, Tourette's Syndrome, Tic Disorders, Dystonia, Movement Disorders
Interventions: Transcranial Direct Current Stimulation (tDCS), Eye-tracking Device, Pulsed vibrator, Gait Trainer Treadmill (GTT), Standard psychiatric scales SCID-I, YBOCS and SCI-OBS-lifetime and cognitive scales MMSE and MOCA, iMobility, QMAT, Treadmill Test, Arm Intellistretch Device, Transcranial Sonography (TCS), Behavioral tasks, TMS single/paired pulse, MEG, EEG, MRI techniques, Peripheral Nerve Stimulation, EMG, Trancutaneous spinal direct current stimulation (tsDCS); Procedure · Device · Other + 1 more
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years and older
Enrollment: 1,273 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids

Ultrasound-Based Imaging Using the Aixplorer System in Diagnosing Prostate Cancer in Patients Undergoing Biopsy

Long-Term Efficacy and Duration of MFU-V at Multiple Depths and at 1.5 mm

Sonomyographic Upper Limb Prosthetics: A New Paradigm

PET/MRI for Evaluation of Endometriosis

Clinical Evaluation of Opto-Acoustic Image Quality With the Gen 2 Imagio System

Image Fusion in the OR

Randomized Controlled Trial for Ankle Fracture Pain Control

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

PACMAN Ultrasound Recording Data Collection

BFR DISTRAD NON OP: Blood Flow Restricted Training During Rehabilitation Following Distal Radius Fracture

Focused Ultrasound to Promote Immune Responses for Undifferentiated Pleomorphic Sarcoma

Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction

MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer

The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)

Feasibility Study: Ulthera® System for the Treatment of Moderate to Severe Facial Acne

MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer

Feasibility Study: Heavy Water Tissue Labeling Protocol

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

ExAblate Transcranial MRgFUS of the Globus Pallidum for Treatment of Parkinson's Disease

Open-label, Prospective Evaluation of the Ulthera® System for Lifting Submental (Under the Chin) and Neck Tissue in Chinese Patients

Physiological Investigations of Movement Disorders